4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-26-003482
Chief Commercial Officer sold 910 shares at an average $493.78 ($449,339)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huntsman Carole Chief Commercial Officer | 2026-01-26 | Sale 10b5-1 | −340 | $492.42 | $167,423 | 9,692 | D |
| Huntsman Carole Chief Commercial Officer | 2026-01-26 | Sale 10b5-1 | −570 | $494.59 | $281,916 | 9,122 | D |
| Open-market sales · 910 sh · avg $493.78 · $449,339 | |||||||
Loading xslF345X05/wk-form4_1769467117.xml…